United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market (2025-2031) | Share, Forecast, Segmentation, Analysis, Industry, Value, Competitive Landscape, Companies, Trends, Outlook, Size & Revenue, Growth

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market - Industry Life Cycle

3.4 United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market - Porter's Five Forces

3.5 United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market Revenues & Volume Share, By Application, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Growing geriatric population in the United States, leading to an increased prevalence of aortic valve diseases.

4.2.2 Technological advancements in transcatheter aortic valve replacement (TAVR) procedures, improving patient outcomes and reducing risks.

4.2.3 Rising awareness about minimally invasive procedures among patients and healthcare providers, driving the adoption of TAVR over traditional surgical options.

4.3 Market Restraints

4.3.1 High costs associated with TAVR procedures, limiting access for some patient populations.

4.3.2 Regulatory challenges and reimbursement issues impacting the adoption and expansion of TAVR procedures in the United States.

6.1 United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market, By Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market Revenues & Volume, By Transfemoral Approach, 2021- 2031F

6.1.4 United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market Revenues & Volume, By Transapical Approach, 2021- 2031F

6.1.5 United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market Revenues & Volume, By Aortic Stenosis, 2021- 2031F

6.2.3 United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market Revenues & Volume, By Aortic Regurgitation, 2021- 2031F

6.2.4 United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market Revenues & Volume, By Others, 2021- 2031F

7.1 United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market Export to Major Countries

7.2 United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market Imports from Major Countries

8.1 Average procedure time for TAVR surgeries, indicating improvements in efficiency and patient outcomes.

8.2 Number of TAVR procedures performed annually, reflecting the growing acceptance and adoption of TAVR in the United States.

8.3 Rate of complications and adverse events post-TAVR procedure, highlighting the safety and reliability of the technology.

9.1 United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market Opportunity Assessment, By Application, 2021 & 2031F

10.1 United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market Revenue Share, By Companies, 2024

10.2 United States (US) Transcatheter Aortic Valve Replacement (TAVR) Market Competitive Benchmarking, By Operating and Technical Parameters